FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA, Others Launch Global Substances System

FDA says it is working with the National Institutes of Health and the European Medicines Agency on a global substance registration system.

latest-news-card-1
Federal Register

Draft Guide on OTC Monograph Fees

Federal Register notice: FDA makes available a draft guidance entitled Assessing User Fees Under the Over-the-Counter Monograph Drug User Fee Program....

latest-news-card-1
Federal Register

Guidance on Pharmaceutical Carcinogenicity Testing

Federal Register notice: FDA makes available a final guidance entitled S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals.

latest-news-card-1
Human Drugs

Oncology Drug Cross Labeling Guidance

FDA publishes a guidance on cross-labeling of oncology drugs used in combination regimens.

latest-news-card-1
Medical Devices

Teleflex Filter Recall is Class 1

FDA says the Teleflex recall of 60,000 Iso-Gard Filter S units is Class 1.

latest-news-card-1
Human Drugs

Temporary Clozapine REMS Enforcement Discretion

FDA announces new enforcement discretion and reiterates previous enforcement discretion relating to issues with the clozapine REMS program.

latest-news-card-1
Federal Register

Guide on Expanded Access for Investigational Drugs

Federal Register notice: FDA makes available a revised draft guidance entitled Expanded Access to Investigational Drugs for Treatment Use: Questions a...

latest-news-card-1
Human Drugs

Guilty Pleas in Drug Kickback Conspiracy

The Justice Department says an Ohio doctor and an Avanir Pharmaceuticals employee have pleaded guilty to their roles in a drug kickback scheme.

latest-news-card-1
Human Drugs

New Requests in Radius Petition Supplement

Radius Health files a supplement to its earlier Tymlos petition with three additional actions it wants FDA to take.

latest-news-card-1
Medical Devices

Petition Seeks Reclassification of BD Mesh/Scaffolds

Cardiac surgeon Hooman Noorchashm petitions the agency asking it to change the classification of Becton Dickinsons poly 4-hydroxybutyrate (P4HB)-based...